EVOLUTION OF AMINO-TERMINAL PRO-B TYPE NATRIURETIC PEPTIDE TESTING IN HEART FAILURE

被引:8
作者
Januzzi, James L. [1 ]
Bayes-Genis, Antoni [2 ]
机构
[1] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[2] Univ Autonoma Barcelona, Dept Med, Inst Catal Ciencies Cardiovasc, Hosp Santa Creu & St Pau,Serv Cardiol, E-08193 Barcelona, Spain
关键词
EMERGENCY-DEPARTMENT PRIDE; SNAKE-VENOM LIGAND; NT-PROBNP; PROGNOSTIC VALUE; DIAGNOSTIC-ACCURACY; COST-EFFECTIVENESS; DYSPNEIC PATIENTS; RENAL-FUNCTION; PRIMARY-CARE; RECEPTOR-A;
D O I
10.1358/dnp.2009.22.5.1378643
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of natriuretic peptide testing has expanded considerably over the recent years. Thanks to clinical trials that have demonstrated significant benefits associated with testing for B-type natriuretic peptide (BNP) and its amino-terminal pro-peptide (NT-proBNP), testing for these peptides is now ubiquitous in modern medicine. This review will focus on the use of NT-proBNP in clinical medicine, with a discussion of the biologic significance of NT-proBNP, its proven present uses and potential future applications.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 68 条
[1]  
[Anonymous], EUR J HEART FAIL, DOI [10.1016/s1567-4215(04)90150-6, DOI 10.1016/S1567-4215(04)90150-6]
[2]   Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement - Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study [J].
Anwaruddin, S ;
Lloyd-Jones, DM ;
Baggish, A ;
Chen, A ;
Krauser, D ;
Tung, R ;
Chae, C ;
Januzzi, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) :91-97
[3]   Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure [J].
Araujo, Jose Paulo ;
Azevedo, Ana ;
Lourenco, Patricia ;
Rocha-Goncalves, Francisco ;
Ferreira, Antonio ;
Bettencourt, Paulo .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (09) :1248-1250
[4]   Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study [J].
Baggish, Aaron L. ;
van Kimmenade, Roland ;
Bayes-Genis, Antoni ;
Davis, Mark ;
Lainchbury, John G. ;
Frampton, Chris ;
Pinto, Yigal ;
Richards, Mark A. ;
Januzzi, James L. .
CLINICA CHIMICA ACTA, 2007, 381 (02) :145-150
[5]  
Baggish Aaron L, 2004, Crit Pathw Cardiol, V3, P171, DOI 10.1097/01.hpc.0000145817.68289.a2
[6]   Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome [J].
Bajwa, Ednan K. ;
Januzzi, James L. ;
Gong, Michelle N. ;
Thompson, B. Taylor ;
Christiani, David C. .
CRITICAL CARE MEDICINE, 2008, 36 (08) :2322-2327
[7]   NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality [J].
Bayés-Genís, A ;
Lopez, L ;
Zapico, E ;
Cotes, C ;
Santalò, M ;
Ordonez-Llanos, J ;
Cinca, J .
JOURNAL OF CARDIAC FAILURE, 2005, 11 (05) :S3-S8
[8]  
Bayes-Genis Antoni, 2006, Timely Top Med Cardiovasc Dis, V10, pE10
[9]   Dendroaspis natriuretic peptide relaxes isolated human arteries and veins [J].
Best, PJM ;
Burnett, JC ;
Wilson, SH ;
Holmes, DR ;
Lerman, A .
CARDIOVASCULAR RESEARCH, 2002, 55 (02) :375-384
[10]   N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [J].
Bettencourt, P ;
Azevedo, A ;
Pimenta, J ;
Frioes, F ;
Ferreira, S ;
Ferreira, A .
CIRCULATION, 2004, 110 (15) :2168-2174